Results 211 to 220 of about 5,138,607 (284)

Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event prevention. [PDF]

Breast
Massa G, Simeone N, Tinè G, Bracchi P, Miceli R, Pigni A, Lo Dico S, Zambelli L, Ricchini F, Bianchi GV, Caraceni A, Zecca E.   +11 more
europepmc   +1 more source

Effect of zoledronic acid on fracture healing in osteoporotic patients with intertrochanteric fractures

, 2017
PrabhnoorSingh Hayer, Anit KumarSamuel Deane, Atul Agrawal, Rajesh Maheshwari, Anil Juyal   +4 more
openalex   +1 more source

Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review. [PDF]

J Bone Oncol
Damaj N, Najdi T, Seif S, Nakouzi N, Kattan J.   +4 more
europepmc   +1 more source

Doxycycline Enhances Anticancer Activity of Zoledronic Acid via Inducing ROS and Autophagy in Osteosarcoma Cell Lines. [PDF]

Int J Med Sci
Li YA, Chen HY, Hsu CS, Tseng SC, Hwang E, Hsieh CP, Hung SC, Huang YF.   +7 more
europepmc   +1 more source

Bilateral Knee Effusions Secondary to Zoledronic Acid Infusion. [PDF]

JCEM Case Rep
Wei J, Cho CSI.
europepmc   +1 more source

Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosis

, 2007

openalex   +1 more source

Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility.

J Clin Endocrinol Metab
Stoffers AJ, Mancilla EE, Levine MA, Mayer M, Monk HM, Rosano J, Weber DR.   +6 more
europepmc   +1 more source

Corrigendum: Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma. [PDF]

Front Bioeng Biotechnol
Xu Y, Qi J, Sun W, Zhong W, Wu H.
europepmc   +1 more source

Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors. [PDF]

Breast
Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri A, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F.   +69 more
europepmc   +1 more source

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia. [PDF]

BMC Musculoskelet Disord
Li W, Xu M, Shi X, Gu J, Guo J, Xu Y, Dai B.   +6 more
europepmc   +1 more source